Neuren Pharmaceuticals Ltd. earnings per share and revenue

NURPF earnings per share for the last semiannual are 0.59 USD whereas the estimation was 0.67 USD which accounts for -12.46% surprise. Company revenue for the same period amounts to 119.61 M USD despite the estimated figure of 112.53 M USD. Estimated earnings per share for the next semiannual are 0.10 USD, and revenue is expected to reach 24.10 M USD. Also watch annual changes over time to get a bigger picture of NURPF earnings per share and revenue dynamics.